Status:
NOT_YET_RECRUITING
Artificial Intelligence in Trapeziometacarpal Joint Osteoarthritis: Improving Assessment and Clinical Decision-Making
Lead Sponsor:
Schulthess Klinik
Collaborating Sponsors:
ETH Zurich (Switzerland)
Conditions:
Thumb Osteoarthritis
Eligibility:
All Genders
Brief Summary
This is a retrospective cohort study utilizing radiographic and computed tomography (CT) imaging data collected during routine clinical care at Schulthess Klinik Zürich. The study focuses on developin...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients will be included in the study if they have provided written general consent for the use of their clinical data and meet the requirements of one of the following two groups:
- TMC OA group:
- • Patients who received a Touch implant for TMC joint arthroplasty and are documented in our clinical registry
- Other clinical conditions:
- • Patients who underwent radiographic imaging for one of the following conditions, with a clearly visible TMC joint, for example: Distal radius fracture, carpal fracture, finger dislocation, or similar.
- Exclusion Criteria:
- The exclusion criteria are defined based on the two inclusion groups:
- TMC OA group:
- Patients with posttraumatic OA.
- Patients with rheumatoid arthritis.
- Other clinical conditions:
- Eaton Littler score higher than one.
- Prior surgery affecting the trapezium or the first metacarpal.
- Clinical condition resulting in abnormal TMC joint morphology.
- Furthermore, patients will also be excluded if they revoke their consent in writing or via verbal withdrawal.
Exclusion
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2028
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT07148349
Start Date
September 1 2025
End Date
August 1 2028
Last Update
September 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Schulthess Klinik
Zurich, Canton of Zurich, Switzerland, 8008